ONWARD MEDICAL BV EO -12 (F:63E) — Stock Price
ONWARD MEDICAL BV EO -12 (F:63E) is currently trading at €2.36 EUR, down 2.28% today. Over the past 52 weeks, shares have ranged between €2.31 and €5.56. This page tracks ONWARD MEDICAL BV EO -12's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ONWARD MEDICAL BV EO -12 market capitalisation.
ONWARD MEDICAL BV EO -12 (63E) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ONWARD MEDICAL BV EO -12's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
ONWARD MEDICAL BV EO -12 Income Statement — Revenue, Profit & Earnings by Year
ONWARD MEDICAL BV EO -12's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €3.78 Million | €229.00K | €68.00K | €104.00K | €0.00 |
| Cost of Revenue | €1.04 Million | €22.00K | €0.00 | €14.69 Million | €11.98 Million |
| Gross Profit | €2.74 Million | €207.00K | €68.00K | €-14.69 Million | €-11.98 Million |
| Research & Development | €12.32 Million | €13.88 Million | €13.84 Million | €13.14 Million | €7.93 Million |
| SG&A | €9.79 Million | €5.68 Million | €6.29 Million | €6.53 Million | €7.76 Million |
| Total Operating Expenses | €44.70 Million | €35.09 Million | €35.53 Million | €32.13 Million | €28.53 Million |
| Operating Income | €-40.92 Million | €-34.86 Million | €-35.46 Million | €-32.03 Million | €-28.53 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €2.22 Million | €2.00 Million | €1.38 Million | €1.51 Million | €5.60 Million |
| Income Before Tax | €-41.48 Million | €-35.77 Million | €-36.07 Million | €-33.54 Million | €-34.24 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-41.79 Million | €-35.73 Million | €-36.18 Million | €-32.77 Million | €-34.31 Million |
ONWARD MEDICAL BV EO -12 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ONWARD MEDICAL BV EO -12's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €84.55 Million | €76.14 Million | €43.63 Million | €76.59 Million | €104.80 Million |
| Total Current Assets | €74.08 Million | €63.62 Million | €31.42 Million | €64.18 Million | €92.39 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | €20.00 Million | — |
| Net Receivables | €1.20 Million | €160.00K | €0.00 | — | — |
| Inventory | €803.00K | €102.00K | €0.00 | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €1.74 Million | €1.96 Million | €1.84 Million | €1.90 Million | €1.70 Million |
| Total Liabilities | €29.24 Million | €28.08 Million | €25.70 Million | €23.96 Million | €22.11 Million |
| Total Current Liabilities | €11.10 Million | €9.29 Million | €6.68 Million | €8.22 Million | €5.54 Million |
| Long-term Debt | €13.07 Million | €13.97 Million | €15.26 Million | €12.66 Million | €11.45 Million |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €55.32 Million | €48.05 Million | €17.93 Million | €52.63 Million | €82.68 Million |
| Retained Earnings | €-222.56 Million | €-181.84 Million | €-145.43 Million | €-108.32 Million | €-75.97 Million |
ONWARD MEDICAL BV EO -12 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ONWARD MEDICAL BV EO -12 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-39.07 Million | €-31.76 Million | €-32.27 Million | €-26.68 Million | €-19.87 Million |
| Capital Expenditures | €432.00K | €150.00K | €422.00K | €417.00K | €2.32 Million |
| Free Cash Flow | €-39.50 Million | €-31.91 Million | €-32.69 Million | €-27.10 Million | €-22.20 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €2.64 Million | €2.72 Million | €2.56 Million | €1.69 Million | €8.56 Million |
| Depreciation | €1.45 Million | €898.00K | €726.00K | €735.00K | €329.00K |
| Change in Cash | €7.85 Million | €30.65 Million | €-11.88 Million | €-47.66 Million | €83.16 Million |
ONWARD MEDICAL BV EO -12 Earnings History — EPS Actual vs. Analyst Estimates
Track ONWARD MEDICAL BV EO -12's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 01, 2026 | — | — | — |
| Mar 31, 2026 | — | — | — |
| Apr 01, 2025 | — | — | — |